Member Info for Hartlebury

CS - welcome back...genuine question, how good is the Avacta LFT at a) identifying new strains of a virus and b)telling the person reading the result which it is?

Lol

Does everyone have their Trellus shares? I don’t seem to have anything in my AJ Bell account. Anyone know what’s going on please?

Seems like all good news...so why does this share seem so unloved?

Yes but the last year would have been a bumper one for Moonpig with people buying cards online rather than in shops...they are also vulnerable to a post covid slump!

A great sign that institutions are seeing NCYT as a serious company - mid cap on the horizon.

That’s what I’m thinking, it makes sense to me but obviously we aren’t totally clear on how many Variplex tests are available immediately...

I can’t see how all 80000 tests could be ours, they need to be done as fast as possible so all available platforms and assays will be put to work, the second stage for those not initially tested using Variplex may involve It though? Cheaper and faster than sequencing...

I don’t know if any where they have forced it but this was in the press recently.. https://www.google.co.uk/amp/s/news.sky.com/story/amp/blackrock-urges-astrazeneca-to-hold-new-talks-10404290

It’s a risky thing to do because you could end up with a very disgruntled GM, who I would say is pretty key to NCYT’s success

More worryingly, it’s being reported that the SA strain isn’t responding to the monoclonal antibody treatment that was being hailed as a saviour :-(

I agree Milcait, I bought more this morning, was planning to anyway after seeing the rise in institutional holdings but the rns sealed it. It shows how agile and responsive NCYT is, they always seem to be ahead of the curve . Also reflected their involvement in global research teams, such connections and solutions will IMO, surely provide great returns.

Hamsters I think, with regard to how they could announce phase 1, the NDA restricts them saying something without the consent of DHSC, iirc there is reference in the contract to DHSC also understanding that as a public company, NCYT has a duty to disclose psi to shareholders. So there’s a balancing act here and that was likely what was being referred to in GM’s email regarding the rns and PR.

London welcome to my world - you will only get abuse for stating facts. The object of the FCA is to maintain an orderly market, this means keeping shares trading unless there is a very good reason not to. It does not involve allowing companies to decide whether to be suspended or not! I can’t believe that anyone with two brain cells can’t see why that would be chaotic!

Whatever the wording in the handbook about ‘requests’, the FCA decides. And it wants perfect information in the market and shares always remaining in trading. Would you really want CEO’s deciding when you can buy or sell shares in their company?

Sorry Bing (facepalm), I did wonder if you were serious :)

It’s not a press release it’s rns, lse alerts have been really slow lately

Sorry neilrich, I think I cross posted with you but I was asking a semi rhetorical question, we have said before that they are limited in what they can say about DHSC revenues, which is why no company is putting out PR in this respect.

Based on what?? FCA doesn’t check accountants work, that’s what auditors are for!

If they have it, there must be a reason why they aren’t shouting about it...just to point out that no one else is claiming it either - why not? Could it be that they aren’t allowed by DHSC?

Yes can be done during the day

And this is why PCR testing is going nowhere